Transcarent has raised a total of $424 million, including a $200 million Series C in January 2022 led by Kinnevik and Human Capital, reaching a $1.62 billion valuation, later rising to $2.2 billion by May 2024. Founded in 2018 and based in San Francisco, Transcarent offers an AI-powered health benefits platform that connects employees to care, guidance, and clinical support. With strong backers such as Ally Bridge Group and Geodesic Capital, Transcarent is scaling its reach in AI-driven employee health management.